価格表

在庫・価格 : 2024年06月19日 21時07分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-Fanconi Anemia D2, Rabbit-Poly <Anti-FANCD2>
データシート
NB100-182 NOVノバス バイオロジカルス
Novus biologicals, LLC
50 μl ¥103,000 1個 追加

在庫・価格 : 2024年06月19日 21時07分 現在

Anti-Fanconi Anemia D2, Rabbit-Poly <Anti-FANCD2>

  • 商品コード:NB100-182
  • メーカー:NOV
  • 包装:50μl
  • 価格: ¥103,000
  • 在庫:1個
使用文献
No. 文献情報 備考 参照
1 Garcia-Higuera I et al. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol. Cell 2001 Feb;7(2):249-62
Garcia-Higuera I et al
2001/01/01
Western blot, Immunofluorescence, human PubMed
2 McMahon LW et al. Human alpha spectrin II and the FANCA, FANCC, and FANCG proteins bind to DNA containing psoralen interstrand cross-links. Biochemistry 2001 Jun;40(24):7025-34
McMahon LW et al
2001/01/01
Western Blot, Immunoprecipitation, Human PubMed
3 Digweed M et al. Attenuation of the formation of DNA-repair foci containing RAD51 in Fanconi anaemia. Carcinogenesis 2002 Jul;23(7):1121-6
Digweed M et al
2002/01/01
PubMed
4 Taniguchi T et al. S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood 2002 Oct;100(7):2414-20
Taniguchi T et al
2002/01/01
Western Blot, Immunofluorescence, human PubMed
5 Sridharan D et al. Nonerythroid alphaII spectrin is required for recruitment of FANCA and XPF to nuclear foci induced by DNA interstrand cross-links. J. Cell. Sci. 2003 Mar;116(Pt 5):823-35
Sridharan D et al
2003/01/01
Immunofluorescence, Immunoprecipitation, Western Blot, human PubMed
6 Lensch MW et al. Acquired FANCA dysfunction and cytogenetic instability in adult acute myelogenous leukemia. Blood 2003 Jul;102(1):7-16
Lensch MW et al
2003/01/01
Western Blot, Human PubMed
7 Taniguchi T et al. Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors. Nat. Med. 2003 May;9(5):568-74
Taniguchi T et al
2003/01/01
Western Blot, Immunoprecipitation, Immunofluorescence, human PubMed
8 Olopade OI et al. FANCF methylation contributes to chemoselectivity in ovarian cancer. Cancer Cell 2003 May;3(5):417-20
Olopade OI et al
2003/01/01
PubMed
9 Rothfuss A et al. Repair kinetics of genomic interstrand DNA cross-links: evidence for DNA double-strand break-dependent activation of the Fanconi anemia/BRCA pathway. Mol. Cell. Biol. 2004 Jan;24(1):123-34
Rothfuss A et al
2004/01/01
Immunofluorescence, Western Blot, human PubMed
10 Donahue SL et al. A Rad50-dependent pathway of DNA repair is deficient in Fanconi anemia fibroblasts. Nucleic Acids Res. 2004;32(10):3248-57
Donahue SL et al
2004/01/01
Human PubMed
11 Stiff T et al. Nbs1 is required for ATR-dependent phosphorylation events. EMBO J. 2005 Jan;24(1):199-208
Stiff T et al
2005/01/01
PubMed
12 Bekker-Jensen S et al. Spatial organization of the mammalian genome surveillance machinery in response to DNA strand breaks. J. Cell Biol. 2006 Apr;173(2):195-206
Bekker-Jensen S et al
2006/01/01
PubMed
13 Tremblay S et al. Young patients with oral squamous cell carcinoma: study of the involvement of GSTP1 and deregulation of the Fanconi anemia genes. Arch. Otolaryngol. Head Neck Surg. 2006 Sep;132(9):958-66
Tremblay S et al
2006/01/01
PubMed
14 Mukhopadhyay SS et al. Defective mitochondrial peroxiredoxin-3 results in sensitivity to oxidative stress in Fanconi anemia. J. Cell Biol. 2006 Oct;175(2):225-35
Mukhopadhyay SS et al
2006/01/01
PubMed
15 Dunn J et al. Activation of the Fanconi anemia/BRCA pathway and recombination repair in the cellular response to solar ultraviolet light. Cancer Res. 2006 Dec;66(23):11140-7
Dunn J et al
2006/01/01
PubMed
16 Oda T et al. Hsp90 regulates the Fanconi anemia DNA damage response pathway. Blood 2007 Jun;109(11):5016-26
Oda T et al
2007/01/01
PubMed
17 Jacquemont C et al. Proteasome function is required for DNA damage response and fanconi anemia pathway activation. Cancer Res. 2007 Aug;67(15):7395-405
Jacquemont C et al
2007/01/01
PubMed
18 Ceccaldi R et al. Spontaneous abrogation of the G&#x2082;DNA damage checkpoint has clinical benefits but promotes leukemogenesis in Fanconi anemia patients. J. Clin. Invest. 2011 Jan;121(1):184-94
Ceccaldi R et al
2011/01/01
PubMed
19 Leung JW et al. Fanconi anemia (FA) binding protein FAAP20 stabilizes FA complementation group A (FANCA) and participates in interstrand cross-link repair. Proc. Natl. Acad. Sci. U.S.A. 2012 Mar;109(12):4491-6
Leung JW et al
2012/01/01
PubMed
20 Howlett NG et al. Functional interaction between the Fanconi Anemia D2 protein and proliferating cell nuclear antigen (PCNA) via a conserved putative PCNA interaction motif. J. Biol. Chem. 2009 Oct;284(42):28935-42
Howlett NG et al
2009/01/01
PubMed
21 Wright JW et al. Ovarian surface epitheliectomy in the non-human primate: continued cyclic ovarian function and limited epithelial replacement. Hum. Reprod. 2011 Jun;26(6):1422-30
Wright JW et al
2011/01/01
PubMed
22 Tremblay CS et al. HES1 is a novel interactor of the Fanconi anemia core complex. Blood 2008 Sep;112(5):2062-70
Tremblay CS et al
2008/01/01
PubMed
23 Dore-Duffy P et al. Immortalized CNS pericytes are quiescent smooth muscle actin-negative and pluripotent. Microvasc. Res. 2011 Jul;82(1):18-27
Dore-Duffy P et al
2011/01/01
PubMed
24 Bilardi RA et al. Processing of anthracycline-DNA adducts via DNA replication and interstrand crosslink repair pathways. Biochem. Pharmacol. 2012 May;83(9):1241-50
Bilardi RA et al
2012/01/01
PubMed
25 Lyakhovich A et al. Constitutive activation of caspase-3 and Poly ADP ribose polymerase cleavage in fanconi anemia cells. Mol. Cancer Res. 2010 Jan;8(1):46-56
Lyakhovich A et al
2010/01/01
PubMed
26 Stoepker C et al. SLX4, a coordinator of structure-specific endonucleases, is mutated in a new Fanconi anemia subtype. Nat. Genet. 2011 Feb;43(2):138-41
Stoepker C et al
2011/01/01
PubMed
27 Kavanaugh GM et al. The human DEK oncogene regulates DNA damage response signaling and repair. Nucleic Acids Res. 2011 Sep;39(17):7465-76
Kavanaugh GM et al
2011/01/01
PubMed
28 Jones MJ et al. Dysregulation of DNA polymerase &#x3BA; recruitment to replication forks results in genomic instability. EMBO J. 2012 Feb;31(4):908-18
Jones MJ et al
2012/01/01
PubMed
29 Baldeyron C et al. HP1alpha recruitment to DNA damage by p150CAF-1 promotes homologous recombination repair. J. Cell Biol. 2011 Apr;193(1):81-95
Baldeyron C et al
2011/01/01
PubMed
30 Yang Y et al. Targeted disruption of the murine Fanconi anemia gene, Fancg/Xrcc9. Blood 2001 Dec;98(12):3435-40
Yang Y et al
2001/01/01
PubMed
31 Kolas NK et al. Orchestration of the DNA-damage response by the RNF8 ubiquitin ligase. Science 2007 Dec;318(5856):1637-40
Kolas NK et al
2007/01/01
PubMed
32 Bhagwat N et al. XPF-ERCC1 participates in the Fanconi anemia pathway of cross-link repair. Mol. Cell. Biol. 2009 Dec;29(24):6427-37
Bhagwat N et al
2009/01/01
PubMed
33 Mason JM et al. Snm1B/Apollo functions in the Fanconi anemia pathway in response to DNA interstrand crosslinks. Hum. Mol. Genet. 2011 Jul;20(13):2549-59
Mason JM et al
2011/01/01
PubMed
34 Brem R et al. Efficient DNA interstrand crosslinking by 6-thioguanine and UVA radiation. DNA Repair (Amst.) 2011 Aug;10(8):869-76
Brem R et al
2011/01/01
PubMed
35 Jacome A et al. Lac operator repeats generate a traceable fragile site in mammalian cells. EMBO Rep. 2011 Oct;12(10):1032-8
Jacome A et al
2011/01/01
PubMed
36 Kim Y et al. Mutations of the SLX4 gene in Fanconi anemia. Nat. Genet. 2011 Feb;43(2):142-6
Kim Y et al
2011/01/01
PubMed
37 Hovest MG et al. Differential roles for Chk1 and FANCD2 in ATR-mediated signalling for psoralen photoactivation-induced senescence. Exp. Dermatol. 2011 Nov;20(11):883-9
Hovest MG et al
2011/01/01
Applications: WB, ICC, IF, Species: Human PubMed
38 An JY et al. UBR2 of the N-end rule pathway is required for chromosome stability via histone ubiquitylation in spermatocytes and somatic cells. PLoS ONE 2012;7(5):e37414
An JY et al
2012/01/01
Applications: ICC, IF, Species: Mouse PubMed
39 Ceccaldi R et al. Bone marrow failure in fanconi anemia is triggered by an exacerbated p53/p21 DNA damage response that impairs hematopoietic stem and progenitor cells. Cell Stem Cell 2012 Jul;11(1):36-49
Ceccaldi R et al
2012/01/01
Species: Human, Applications: WB, ICC/IF PubMed
40 Panneerselvam J et al. FAVL impairment of the Fanconi anemia pathway promotes the development of human bladder cancer. Cell Cycle 2012 Aug;11(15):2947-55
Panneerselvam J et al
2012/01/01
Species: Human, Applications: WB, ICC/IF PubMed
41 Wang Y et al. MiR-96 downregulates REV1 and RAD51 to promote cellular sensitivity to cisplatin and PARP inhibition. Cancer Res. 2012 Aug;72(16):4037-46
Wang Y et al
2012/01/01
Species: Human, Applications: ICC/IF PubMed
42 Hoskins EE et al. The fanconi anemia pathway limits human papillomavirus replication. J. Virol. 2012 Aug;86(15):8131-8
Hoskins EE et al
2012/01/01
Species: Human, Applications: WB PubMed
43 Rego MA et al. Regulation of the Fanconi anemia pathway by a CUE ubiquitin-binding domain in the FANCD2 protein. Blood 2012 Sep;120(10):2109-17
Rego MA et al
2012/01/01
PubMed
44 . ;

Applications: WB PubMed
45 Duan W et al. Assessment of FANCD2 nuclear foci formation in paraffin-embedded tumors: a potential patient-enrichment strategy for treatment with DNA interstrand crosslinking agents. Transl Res 2012 Oct;
Duan W et al
2012/01/01
Species: Human, Applications: ICC/IF, IHC, IF PubMed
46 Jacquemont C et al. Non-specific chemical inhibition of the Fanconi anemia pathway sensitizes cancer cells to cisplatin. Mol. Cancer 2012;11:26
Jacquemont C et al
2012/01/01
Species: Human, Applications: ICC/IF, WB PubMed
47 Kim Y et al. Regulation of multiple DNA repair pathways by the Fanconi anemia protein SLX4. Blood 2012 Oct;
Kim Y et al
2012/01/01
PubMed
48 Yüce Ö et al. Senataxin, defective in the neurodegenerative disorder ataxia with oculomotor apraxia 2, lies at the interface of transcription and the DNA damage response. Mol. Cell. Biol. 2013 Jan;33(2):406-17
Yüce Ö et al
2013/01/01
Species: Human, Applications: ICC/IF PubMed
49 Ogi T et al. Identification of the first ATRIP-deficient patient and novel mutations in ATR define a clinical spectrum for ATR-ATRIP Seckel Syndrome. PLoS Genet. 2012;8(11):e1002945
Ogi T et al
2012/01/01
Species: Human, Applications: WB PubMed
50 Bhat A et al. Rev3, the catalytic subunit of Pol&#x3B6;, is required for maintaining fragile site stability in human cells. Nucleic Acids Res. 2013 Feb;41(4):2328-39
Bhat A et al
2013/01/01
Species: Human, Applications: ICC/IF PubMed
51 Gravells P et al. Reduced FANCD2 influences spontaneous SCE and RAD51 foci formation in uveal melanoma and Fanconi anaemia. Oncogene 2013 Jan;
Gravells P et al
2013/01/01
Species: Human, Applications: WB PubMed
52 Wang Y et al. FANCM and FAAP24 Maintain Genome Stability via Cooperative as Well as Unique Functions. Mol. Cell 2013 Mar;49(5):997-1009
Wang Y et al
2013/01/01
Species: Human, Applications: WB, ICC/IF PubMed
53 Duquette ML et al. CtIP is required to initiate replication-dependent interstrand crosslink repair. PLoS Genet. 2012;8(11):e1003050
Duquette ML et al
2012/01/01
Species: Human, Applications: ICC/IF PubMed
54 Fu D et al. Recruitment of DNA polymerase eta by FANCD2 in the early response to DNA damage. Cell Cycle 2013 Mar;12(5):803-9
Fu D et al
2013/01/01
Species: Human, Applications: WB PubMed
55 Zhang P et al. Non-erythroid alpha spectrin prevents telomere dysfunction after DNA interstrand cross-link damage. Nucleic Acids Res. 2013 May;41(10):5321-40
Zhang P et al
2013/01/01
Species: Human, Applications: ICC/IF PubMed
56 Rego MA et al. Regulation of the activation of the Fanconi anemia pathway by the p21 cyclin-dependent kinase inhibitor. Oncogene 2012 Jan;31(3):366-75
Rego MA et al
2012/01/01
Species: Human, Applications: WB, ICC/IF PubMed
57 Tomida J et al. A novel interplay between the Fanconi anemia core complex and ATR-ATRIP kinase during DNA cross-link repair. Nucleic Acids Res. 2013 May;
Tomida J et al
2013/01/01
Species: Human, Applications: WB PubMed
58 Mason JM et al. The SNM1B/APOLLO DNA nuclease functions in resolution of replication stress and maintenance of common fragile site stability. Hum. Mol. Genet. 2013 Jul;
Mason JM et al
2013/01/01
Species: Human, Applications: WB, ICC/IF PubMed
59 Ying S et al. MUS81 promotes common fragile site expression. Nat. Cell Biol. 2013 Aug;15(8):1001-7
Ying S et al
2013/01/01
Species: Human, Applications: ICC/IF PubMed
60 Colnaghi L et al. Patient-derived C-terminal mutation of FANCI causes protein mislocalization and reveals putative EDGE motif function in DNA repair. Blood 2011 Feb;117(7):2247-56
Colnaghi L et al
2011/01/01
Species: Human, Applications: ICC/IF PubMed
61 Pf辰ffle HN et al. EGFR-activating mutations correlate with a Fanconi anemia-like cellular phenotype that includes PARP inhibitor sensitivity. Cancer Res. 2013 Oct;73(20):6254-63
Pf辰ffle HN et al
2013/01/01
Species: Human, Applications: ICC/IF PubMed
62 Wang Y et al. Structure analysis of FAAP24 reveals single-stranded DNA-binding activity and domain functions in DNA damage response. Cell Res. 2013 Oct;23(10):1215-28
Wang Y et al
2013/01/01
Species: Human, Applications: WB PubMed
63 Coulthard R et al. Architecture and DNA recognition elements of the Fanconi anemia FANCM-FAAP24 complex. Structure 2013 Sep;21(9):1648-58
Coulthard R et al
2013/01/01
Species: Human, Applications: WB PubMed
64 Jun DW et al. Ouabain, a cardiac glycoside, inhibits the Fanconi anemia/BRCA pathway activated by DNA interstrand cross-linking agents. PLoS ONE 2013;8(10):e75905
Jun DW et al
2013/01/01
PubMed
65 Boisvert RA et al. Coordinate nuclear targeting of the FANCD2 and FANCI proteins via a FANCD2 nuclear localization signal. PLoS ONE 2013;8(11):e81387
Boisvert RA et al
2013/01/01
PubMed
66 Figueiredo N et al. Anthracyclines induce DNA damage response-mediated protection against severe sepsis. Immunity 2013 Nov;39(5):874-84
Figueiredo N et al
2013/01/01
PubMed
67 Chlon TM et al. High-risk human papillomavirus E6 protein promotes reprogramming of Fanconi anemia patient cells through repression of p53 but does not allow for sustained growth of induced pluripotent stem cells. J. Virol. 2014 Oct;88(19):11315-26
Chlon TM et al
2014/01/01
Species: Human, Applications: WB PubMed
68 Panneerselvam J et al. Basal level of FANCD2 monoubiquitination is required for the maintenance of a sufficient number of licensed-replication origins to fire at a normal rate. Oncotarget 2014 Mar;5(5):1326-37
Panneerselvam J et al
2014/01/01
Species: Human, Applications: WB PubMed
69 Bursomanno S et al. Proteome-wide analysis of SUMO2 targets in response to pathological DNA replication stress in human cells. DNA Repair (Amst.) 2015 Jan;25:84-96
Bursomanno S et al
2015/01/01
Species: Human, Applications: WB PubMed
70 Huard CC et al. The Fanconi anemia pathway has a dual function in Dickkopf-1 transcriptional repression. Proc. Natl. Acad. Sci. U.S.A. 2014 Feb;111(6):2152-7
Huard CC et al
2014/01/01
Species: Human, Applications: WB PubMed
71 Stoepker C et al. DNA helicases FANCM and DDX11 are determinants of PARP inhibitor sensitivity. DNA Repair (Amst.) 2015 Feb;26:54-64
Stoepker C et al
2015/01/01
Species: Human, Applications: ICC/IF PubMed
72 Duan W et al. Fanconi anemia repair pathway dysfunction, a potential therapeutic target in lung cancer. Front Oncol 2014;4:368
Duan W et al
2014/01/01
Species: Human, Applications: WB, IHC-P PubMed
73 Brem R et al. UVA photoactivation of DNA containing halogenated thiopyrimidines induces cytotoxic DNA lesions. J. Photochem. Photobiol. B, Biol. 2015 Apr;145:1-10
Brem R et al
2015/01/01
Species: Human, Applications: WB PubMed
74 Aarts M et al. Functional Genetic Screen Identifies Increased Sensitivity to WEE1 Inhibition in Cells with Defects in Fanconi Anemia and HR Pathways. Mol. Cancer Ther. 2015 Apr;14(4):865-76
Aarts M et al
2015/01/01
Species: Human, Applications: WB PubMed
75 Zhu B et al. K63-linked ubiquitination of FANCG is required for its association with the Rap80-BRCA1 complex to modulate homologous recombination repair of DNA interstand crosslinks. Oncogene 2014 Aug;
Zhu B et al
2014/01/01
PubMed
76 Sarbajna S et al. Roles of SLX1-SLX4, MUS81-EME1, and GEN1 in avoiding genome instability and mitotic catastrophe. Genes Dev. 2014 May;28(10):1124-36
Sarbajna S et al
2014/01/01
Species: Human, Applications: ICC/IF PubMed
77 Xie J et al. RNF4-mediated polyubiquitination regulates the Fanconi anemia/BRCA pathway. J. Clin. Invest. 2015 Apr;125(4):1523-32
Xie J et al
2015/01/01
Species: Human, Applications: ICC/IF PubMed
78 Silva BA et al. DNA damage to a single chromosome end delays anaphase onset. J. Biol. Chem. 2014 Aug;289(33):22771-84
Silva BA et al
2014/01/01
PubMed
79 Le VT et al. The cytomegaloviral protein pUL138 acts as potentiator of tumor necrosis factor (TNF) receptor 1 surface density to enhance ULb&quot;-encoded modulation of TNF-&#x3B1; signaling. J. Virol. 2011 Dec;85(24):13260-70
Le VT et al
2011/01/01
Applications: WB PubMed
80 Demuth I et al. Human SNM1B is required for normal cellular response to both DNA interstrand crosslink-inducing agents and ionizing radiation. Oncogene 2004 Nov;23(53):8611-8
Demuth I et al
2004/01/01
Species: Human, Applications: IP PubMed
81 Lu WT et al. The Fanconi anemia pathway is downregulated upon macrophage differentiation through two distinct mechanisms. Cell Cycle 2011 Oct;10(19):3300-10
Lu WT et al
2011/01/01
Species: Human PubMed
82 Smogorzewska A et al. A genetic screen identifies FAN1, a Fanconi anemia-associated nuclease necessary for DNA interstrand crosslink repair. Mol. Cell 2010 Jul;39(1):36-47
Smogorzewska A et al
2010/01/01
PubMed
83 MacKay C et al. Identification of KIAA1018/FAN1, a DNA repair nuclease recruited to DNA damage by monoubiquitinated FANCD2. Cell 2010 Jul;142(1):65-76
MacKay C et al
2010/01/01
Species: Human, Applications: ICC/IF PubMed
84 Rickman KA et al. Deficiency of UBE2T, the E2&#xA0;Ubiquitin Ligase Necessary for FANCD2 and FANCI Ubiquitination, Causes FA-T Subtype of Fanconi Anemia. Cell Rep 2015 Jul;12(1):35-41
Rickman KA et al
2015/01/01
PubMed
85 Chun MJ et al. Aurora A kinase is required for activation of the Fanconi anemia/BRCA pathway upon DNA damage. FEBS Open Bio 2016 Jul;6(7):782-90
Chun MJ et al
2016/01/01
PubMed
86 Raya A et al. Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature 2009 Jul;460(7251):53-9
Raya A et al
2009/01/01
PubMed
87 Stoepker C et al. Defects in the Fanconi Anemia Pathway and Chromatid Cohesion in Head and Neck Cancer. Cancer Res. 2015 Sep;75(17):3543-53
Stoepker C et al
2015/01/01
PubMed
88 Zhou W et al. FAN1 mutations cause karyomegalic interstitial nephritis, linking chronic kidney failure to defective DNA damage repair. Nat. Genet. 2012 Aug;44(8):910-5
Zhou W et al
2012/01/01
PubMed
89 Maeda J et al. Intrinsic Radiosensitivity and Cellular Characterization of 27 Canine Cancer Cell Lines. PLoS ONE 2016;11(6):e0156689
Maeda J et al
2016/01/01
PubMed
90 Root H et al. FANCD2 limits BLM-dependent telomere instability in the alternative lengthening of telomeres pathway. Hum. Mol. Genet. 2016 Jul;
Root H et al
2016/01/01
PubMed
91 Collis SJ et al. HCLK2 is essential for the mammalian S-phase checkpoint and impacts on Chk1 stability. Nat. Cell Biol. 2007 Apr;9(4):391-401
Collis SJ et al
2007/01/01
PubMed
92 Oka Y et al. Ubiquitin-like protein UBL5 promotes the functional integrity of the Fanconi anemia pathway. EMBO J. 2015 May;34(10):1385-98
Oka Y et al
2015/01/01
PubMed
93 Zhang T et al. Loss of Faap20 Causes Hematopoietic Stem and Progenitor Cell Depletion in Mice Under Genotoxic Stress. Stem Cells 2015 Jul;33(7):2320-30
Zhang T et al
2015/01/01
PubMed
94 Panneerselvam J et al. BLM promotes the activation of Fanconi Anemia signaling pathway. Oncotarget 2016 May;7(22):32351-61
Panneerselvam J et al
2016/01/01
PubMed
95 Minocherhomji S et al. Replication stress activates DNA repair synthesis in mitosis. Nature 2015 Dec;528(7581):286-90
Minocherhomji S et al
2015/01/01
PubMed
96 Wang F et al. Leukemic survival factor SALL4 contributes to defective DNA damage repair. Oncogene 2016 May;
Wang F et al
2016/01/01
PubMed
97 Bouffard F et al. Analysis of a FANCE Splice Isoform in Regard to DNA Repair. J. Mol. Biol. 2015 Sep;427(19):3056-73
Bouffard F et al
2015/01/01
PubMed
98 Deans AJ et al. FANCM connects the genome instability disorders Bloom&quot;s Syndrome and Fanconi Anemia. Mol. Cell 2009 Dec;36(6):943-53
Deans AJ et al
2009/01/01
PubMed
99 Ellwood SR et al. A first genome assembly of the barley fungal pathogen Pyrenophora teres f. teres. Genome Biol. 2010;11(11):R109
Ellwood SR et al
2010/01/01
PubMed
100 Puri S et al. Control of bacterial iron homeostasis by manganese. Proc. Natl. Acad. Sci. U.S.A. 2010 Jun;107(23):10691-5
Puri S et al
2010/01/01
PubMed
101 Willers H et al. Biomarkers and mechanisms of FANCD2 function. J. Biomed. Biotechnol. 2008;2008:821529
Willers H et al
2008/01/01
PubMed
102 Puspasari N et al. Long range regulation of human FXN gene expression. PLoS ONE 2011;6(7):e22001
Puspasari N et al
2011/01/01
PubMed
103 Fairclough SR et al. Multicellular development in a choanoflagellate. Curr. Biol. 2010 Oct;20(20):R875-6
Fairclough SR et al
2010/01/01
PubMed
104 Rivera T et al. Recycling cohesin rings by deacetylation. Mol. Cell 2010 Sep;39(5):657-9
Rivera T et al
2010/01/01
PubMed
105 Hays LE. Multifunctionality of the FA pathway. Blood 2013 Jan;121(1):3-4
Hays LE
2013/01/01
PubMed
106 Asur RS et al. Somatic mosaicism of an intragenic FANCB duplication in both fibroblast and peripheral blood cells observed in a Fanconi anemia patient leads to milder phenotype. Mol Genet Genomic Med 2018 01;6(1):77-91
Asur RS et al
2018/01/01
Species: Human, Applications: WB, ICC/IF PubMed
107 Bharathan SP et al. Generation of an induced pluripotent stem cell line that mimics the disease phenotypes from a patient with Fanconi anemia by conditional complementation. Stem Cell Res 2017 04;20:54-57
Bharathan SP et al
2017/01/01
Species: Human, Applications: ICC/IF PubMed
108 Bou Samra E et al. A role for Tau protein in maintaining ribosomal DNA stability and cytidine deaminase-deficient cell survival. Nat Commun 2017 Sep;8(1):693
Bou Samra E et al
2017/01/01
Species: Human, Applications: ICC/IF PubMed
109 Porro A et al. FAN1 interaction with ubiquitylated PCNA alleviates replication stress and preserves genomic integrity independently of BRCA2. Nat Commun 2017 10;8(1):1073
Porro A et al
2017/01/01
Species: Human, Applications: WB PubMed
110 Alavattam KG et al. Elucidation of the Fanconi Anemia Protein Network in Meiosis and Its Function in the Regulation of Histone Modifications. Cell Rep 2016 10;17(4):1141-1157
Alavattam KG et al
2016/01/01
Species: Human, Applications: WB PubMed
111 Balcerek J et al. Lnk/Sh2b3 deficiency restores hematopoietic stem cell function and genome integrity in Fancd2 deficient Fanconi anemia. Nat Commun 2018 09;9(1):3915
Balcerek J et al
2018/01/01
Species: Mouse, Applications: WB PubMed
112 Chun MJ et al. Fanconi anemia protein FANCD2 is activated by AICAR, a modulator of AMPK and cellular energy metabolism. FEBS Open Bio 2017 Feb;7(2):284-292
Chun MJ et al
2017/01/01
Species: Human, Applications: WB, ICC/IF PubMed
113 Andrews AM et al. A senataxin-associated exonuclease SAN1 is required for resistance to DNA interstrand cross-links. Nat Commun 2018 07;9(1):2592
Andrews AM et al
2018/01/01
Species: Human, Applications: WB PubMed
114 Sato K et al. FANCI-FANCD2 stabilizes the RAD51-DNA complex by binding RAD51 and protects the 5&quot;-DNA end. Nucleic Acids Res. 2016 12;44(22):10758-10771
Sato K et al
2016/01/01
Species: Human, Applications: RNAi, WB PubMed
115 Jiang J et al. Arsenite Binds to the RING Finger Domain of FANCL E3 Ubiquitin Ligase and Inhibits DNA Interstrand Crosslink Repair. ACS Chem. Biol. 2017 07;12(7):1858-1866
Jiang J et al
2017/01/01
PubMed
116 Tremblay CS et al. Fanconi anemia core complex-dependent HES1 mono-ubiquitination regulates its transcriptional activity. BMC Res Notes 2018 Feb;11(1):138
Tremblay CS et al
2018/01/01
Species: Human, Applications: PubMed
117 Bezine E et al. Cell resistance to the Cytolethal Distending Toxin involves an association of DNA repair mechanisms. Sci Rep 2016 Oct;6:36022
Bezine E et al
2016/01/01
Species: Human, Applications: WB PubMed
118 Vuono EA et al. The PTEN phosphatase functions cooperatively with the Fanconi anemia proteins in DNA crosslink repair. Sci Rep 2016 11;6:36439
Vuono EA et al
2016/01/01
Species: Human, Applications: PubMed
119 Moriel-Carretero M et al. Fanconi anemia FANCD2 and FANCI proteins regulate the nuclear dynamics of splicing factors. J. Cell Biol. 2017 12;216(12):4007-4026
Moriel-Carretero M et al
2017/01/01
Species: Human, Applications: PubMed
120 Higgs MR et al. Histone Methylation by SETD1A Protects Nascent DNA through the Nucleosome Chaperone Activity of FANCD2. Mol. Cell 2018 Jul;71(1):25-41.e6
Higgs MR et al
2018/01/01
Species: Human, Applications: PubMed
121 Vierra DA et al. Modulation of the Fanconi anemia pathway <i>via</i> chemically induced changes in chromatin structure. Oncotarget 2017 Sep;8(44):76443-76457
Vierra DA et al
2017/01/01
Species: Human, Applications: WB, ICC/IF PubMed
122 Preiss MR et al. Tuning the Multifunctionality of Iron Oxide Nanoparticles Using Self-Assembled Mixed Lipid Layers. Bioconjug. Chem. 2017 11;28(11):2729-2736
Preiss MR et al
2017/01/01
WB PubMed
123 Spriggs CC et al. FANCD2 Binds Human Papillomavirus Genomes and Associates with a Distinct Set of DNA Repair Proteins to Regulate Viral Replication. MBio 2017 02;8(1)
Spriggs CC et al
2017/01/01
PubMed
124 Kais Z et al. FANCD2 Maintains Fork Stability in BRCA1/2-Deficient Tumors and Promotes Alternative End-Joining DNA Repair. Cell Rep 2016 06;15(11):2488-99
Kais Z et al
2016/01/01
WB PubMed
125 Marchesini M et al. ILF2 Is a Regulator of RNA Splicing and DNA Damage Response in 1q21-Amplified Multiple Myeloma. Cancer Cell 2017 07;32(1):88-100.e6
Marchesini M et al
2017/01/01
Species: Human, Applications: PubMed
126 Michl J et al. FANCD2 limits replication stress and genome instability in cells lacking BRCA2. Nat. Struct. Mol. Biol. 2016 08;23(8):755-757
Michl J et al
2016/01/01
Species: Human, Applications: WB PubMed
127 Niraj J et al. The identification of FANCD2 DNA binding domains reveals nuclear localization sequences. Nucleic Acids Res. 2017 Aug;45(14):8341-8357
Niraj J et al
2017/01/01
Species: Human, Applications: WB PubMed
128 Hooks KB et al. New insights into diagnosis and therapeutic options for proliferative hepatoblastoma. Hepatology 2018 07;68(1):89-102
Hooks KB et al
2018/01/01
Species: Human, Applications: WB, ICC/IF PubMed
129 Feng W et al. BRCA2 suppresses replication stress-induced mitotic and G1 abnormalities through homologous recombination. Nat Commun 2017 09;8(1):525
Feng W et al
2017/01/01
Species: Human, Applications: ICC/IF PubMed
130 Kim J et al. Replication Stress Shapes a Protective Chromatin Environment across Fragile Genomic Regions. Mol. Cell 2018 01;69(1):36-47.e7
Kim J et al
2018/01/01
Species: Human, Applications: ICC/IF PubMed
131 Sakasai R et al. Aquarius is required for proper CtIP expression and homologous recombination repair. Sci Rep 2017 Oct;7(1):13808
Sakasai R et al
2017/01/01
Species: Human, Applications: WB PubMed
132 Chang EY et al. RECQ-like helicases Sgs1 and BLM regulate R-loop-associated genome instability. J. Cell Biol. 2017 12;216(12):3991-4005
Chang EY et al
2017/01/01
Species: Human, Applications: PubMed
133 Tacconi EM et al. BRCA1 and BRCA2 tumor suppressors protect against endogenous acetaldehyde toxicity. EMBO Mol Med 2017 10;9(10):1398-1414
Tacconi EM et al
2017/01/01
Species: Mouse, Applications: WB PubMed
134 Lv Z et al. S.&#xA0;pombe Uba1-Ubc15 Structure Reveals a Novel Regulatory Mechanism of Ubiquitin E2 Activity. Mol. Cell 2017 Feb;65(4):699-714.e6
Lv Z et al
2017/01/01
WB PubMed
135 Fu C et al. Dearth and Delayed Maturation of Testicular Germ Cells in Fanconi Anemia E Mutant Male Mice. PLoS ONE 2016;11(8):e0159800
Fu C et al
2016/01/01
IHC PubMed
136 Zhu J et al. FANCD2 influences replication fork processes and genome stability in response to clustered DSBs. Cell Cycle 2015;14(12):1809-22
Zhu J et al
2015/01/01
WB PubMed
137 Huang Y et al. Modularized functions of the Fanconi anemia core complex. Cell Rep 2014 Jun;7(6):1849-57
Huang Y et al
2014/01/01
PubMed
138 Bi J et al. MTDH/AEG-1 downregulation using pristimerin-loaded nanoparticles inhibits Fanconi anemia proteins and increases sensitivity to platinum-based chemotherapy. Gynecol Oncol 2019 11;155(2):349-358
Bi J et al
2019/01/01
PubMed
139 Sonneville R et al. TRAIP drives replisome disassembly and mitotic DNA repair synthesis at sites of incomplete DNA replication. Elife 2019 09;8
Sonneville R et al
2019/01/01
PubMed
140 Miller HE et al. Reconstruction of Ewing Sarcoma Developmental Context from Mass-Scale Transcriptomics Reveals Characteristics of EWSR1-FLI1 Permissibility. Cancers (Basel) 2020 Apr;12(4)
Miller HE et al
2020/01/01
PubMed
141 Johnson SF et al. CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer. Cell Rep 2016 11;17(9):2367-2381
Johnson SF et al
2016/01/01
PubMed
142 Wilkes DC et al. A germline FANCA alteration that is associated with increased sensitivity to DNA damaging agents. Cold Spring Harb Mol Case Stud 2017 Sep;3(5)
Wilkes DC et al
2017/01/01
PubMed
143 Shao X et al. A distinct role for recombination repair factors in an early cellular response to transcription-replication conflicts. Nucleic Acids Res 2020 06;48(10):5467-5484
Shao X et al
2020/01/01
PubMed
144 Tacconi EM et al. Chlorambucil targets BRCA1/2-deficient tumours and counteracts PARP inhibitor resistance. EMBO Mol Med 2019 07;11(7):e9982
Tacconi EM et al
2019/01/01
PubMed
145 Paquin KL et al. FANCD2 Binding to H4K20me2 via a Methyl-Binding Domain Is Essential for Efficient DNA Cross-Link Repair. Mol. Cell. Biol. 2019 08;39(15)
Paquin KL et al
2019/01/01
PubMed
146 Kreutmair S et al. Loss of the Fanconi anemia-associated protein NIPA causes bone marrow failure. J Clin Invest 2020 06;130(6):2827-2844
Kreutmair S et al
2020/01/01
PubMed
147 Brannvoll A et al. The ZGRF1 Helicase Promotes Recombinational Repair of Replication-Blocking DNA Damage in Human Cells. Cell Rep 2020 07;32(1):107849
Brannvoll A et al
2020/01/01
PubMed
148 Ardeljan D et al. Cell fitness screens reveal a conflict between LINE-1 retrotransposition and DNA replication. Nat Struct Mol Biol 2020 02;27(2):168-178
Ardeljan D et al
2020/01/01
PubMed
149 Gemble S et al. Topoisomerase II&#x3B1; prevents ultrafine anaphase bridges by two mechanisms. Open Biol 2020 05;10(5):190259
Gemble S et al
2020/01/01
PubMed
150 Chang EY et al. MRE11-RAD50-NBS1 promotes Fanconi Anemia R-loop suppression at transcription-replication conflicts. Nat Commun 2019 09;10(1):4265
Chang EY et al
2019/01/01
PubMed
151 Li N et al. Cooperation of the NEIL3 and Fanconi anemia/BRCA pathways in interstrand crosslink repair. Nucleic Acids Res 2020 04;48(6):3014-3028
Li N et al
2020/01/01
PubMed
152 Achuthankutty D et al. Regulation of ETAA1-mediated ATR activation couples DNA replication fidelity and genome stability. J Cell Biol 2019 12;218(12):3943-3953
Achuthankutty D et al
2019/01/01
PubMed
153 Cai MY et al. Cooperation of the ATM and Fanconi Anemia/BRCA Pathways in Double-Strand Break End Resection. Cell Rep 2020 02;30(7):2402-2415.e5
Cai MY et al
2020/01/01
PubMed
154 Kono T et al. Activation of DNA damage repair factors in HPV positive oropharyngeal cancers. Virology 2020 08;547:27-34
Kono T et al
2020/01/01
PubMed
155 Mason JM et al. Non-enzymatic roles of human RAD51 at stalled replication forks. Nat Commun 2019 09;10(1):4410
Mason JM et al
2019/01/01
PubMed
156 Xing M et al. Replication Stress Induces ATR/CHK1-Dependent Nonrandom Segregation of Damaged Chromosomes. Mol Cell 2020 05;78(4):714-724.e5
Xing M et al
2020/01/01
PubMed
157 Fragkos M et al. Dicer prevents genome instability in response to replication stress. Oncotarget 2019 Jul;10(43):4407-4423
Fragkos M et al
2019/01/01
PubMed
158 Olivieri M et al. A Genetic Map of the Response to DNA Damage in Human Cells. Cell 2020 07;182(2):481-496.e21
Olivieri M et al
2020/01/01
PubMed
159 Yang Y et al. FANCL gene mutations in premature ovarian insufficiency. Hum Mutat 2020 05;41(5):1033-1041
Yang Y et al
2020/01/01
PubMed
160 Gemble S et al. Identification and Analysis of Different Types of UFBs. Methods Mol Biol 2021;2153:187-192
Gemble S et al
2021/01/01
PubMed
161 Ruiz-Torres S et al. Inherited DNA Repair Defects Disrupt the Structure and Function of Human Skin. Cell Stem Cell 2021 03;28(3):424-435.e6
Ruiz-Torres S et al
2021/01/01
PubMed
162 Lach FP et al. Esophageal cancer as initial presentation of Fanconi anemia in patients with a hypomorphic <i>FANCA</i> variant. Cold Spring Harb Mol Case Stud 2020 12;6(6)
Lach FP et al
2020/01/01
PubMed
163 Calzetta NL et al. Mus81-Eme1-dependent aberrant processing of DNA replication intermediates in mitosis impairs genome integrity. Sci Adv 2020 12;6(50)
Calzetta NL et al
2020/01/01
PubMed
164 Di Marco S et al. RECQ5 Helicase Cooperates with MUS81 Endonuclease in Processing Stalled Replication Forks at Common Fragile Sites during Mitosis. Mol Cell 2017 Jun;66(5):658-671.e8
Di Marco S et al
2017/01/01
PubMed
165 Gonz叩lez-Acosta D et al. PrimPol-mediated repriming facilitates replication traverse of DNA interstrand crosslinks. EMBO J 2021 Jul;40(14):e106355
Gonz叩lez-Acosta D et al
2021/01/01
PubMed
166 Fang X et al. The HMGB1-AGER-STING1 pathway mediates the sterile inflammatory response to alkaliptosis. Biochem Biophys Res Commun 2021 06;560:165-171
Fang X et al
2021/01/01
PubMed
167 Ishimoto R et al. SLX4-XPF mediates DNA damage responses to replication stress induced by DNA-protein interactions. J Cell Biol 2021 01;220(1)
Ishimoto R et al
2021/01/01
PubMed
168 Jones MJK et al. Human DDK rescues stalled forks and counteracts checkpoint inhibition at unfired origins to complete DNA replication. Mol Cell 2021 02;81(3):426-441.e8
Jones MJK et al
2021/01/01
PubMed
169 Watts LP et al. The RIF1-long splice variant promotes G1 phase 53BP1 nuclear bodies to protect against replication stress. Elife 2020 11;9
Watts LP et al
2020/01/01
PubMed
170 Duan W et al. MiRNA-200C expression in Fanconi anemia pathway functionally deficient lung cancers. Sci Rep 2021 Feb;11(1):4420
Duan W et al
2021/01/01
PubMed
171 Zhang T et al. Fancd2 in vivo interaction network reveals a non-canonical role in mitochondrial function. Sci Rep 2017 04;7:45626
Zhang T et al
2017/01/01
PubMed
172 Young SJ et al. MutS&#x3B2; Stimulates Holliday Junction Resolution by the SMX Complex. Cell Rep 2020 10;33(3):108289
Young SJ et al
2020/01/01
PubMed
173 Ma C et al. TFG-maintaining stability of overlooked FANCD2 confers early DNA-damage response. Aging (Albany NY) 2020 10;12(20):20268-20284
Ma C et al
2020/01/01
PubMed
174 Ren L et al. Potential biomarkers of DNA replication stress in cancer. Oncotarget 2017 Jun;8(23):36996-37008
Ren L et al
2017/01/01
PubMed
  • No.: 1
  • 文献情報:
    Garcia-Higuera I et al. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol. Cell 2001 Feb;7(2):249-62
    Garcia-Higuera I et al
    2001/01/01
  • 備考:
    Western blot, Immunofluorescence, human
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    McMahon LW et al. Human alpha spectrin II and the FANCA, FANCC, and FANCG proteins bind to DNA containing psoralen interstrand cross-links. Biochemistry 2001 Jun;40(24):7025-34
    McMahon LW et al
    2001/01/01
  • 備考:
    Western Blot, Immunoprecipitation, Human
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Digweed M et al. Attenuation of the formation of DNA-repair foci containing RAD51 in Fanconi anaemia. Carcinogenesis 2002 Jul;23(7):1121-6
    Digweed M et al
    2002/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Taniguchi T et al. S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood 2002 Oct;100(7):2414-20
    Taniguchi T et al
    2002/01/01
  • 備考:
    Western Blot, Immunofluorescence, human
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Sridharan D et al. Nonerythroid alphaII spectrin is required for recruitment of FANCA and XPF to nuclear foci induced by DNA interstrand cross-links. J. Cell. Sci. 2003 Mar;116(Pt 5):823-35
    Sridharan D et al
    2003/01/01
  • 備考:
    Immunofluorescence, Immunoprecipitation, Western Blot, human
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Lensch MW et al. Acquired FANCA dysfunction and cytogenetic instability in adult acute myelogenous leukemia. Blood 2003 Jul;102(1):7-16
    Lensch MW et al
    2003/01/01
  • 備考:
    Western Blot, Human
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Taniguchi T et al. Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors. Nat. Med. 2003 May;9(5):568-74
    Taniguchi T et al
    2003/01/01
  • 備考:
    Western Blot, Immunoprecipitation, Immunofluorescence, human
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Olopade OI et al. FANCF methylation contributes to chemoselectivity in ovarian cancer. Cancer Cell 2003 May;3(5):417-20
    Olopade OI et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Rothfuss A et al. Repair kinetics of genomic interstrand DNA cross-links: evidence for DNA double-strand break-dependent activation of the Fanconi anemia/BRCA pathway. Mol. Cell. Biol. 2004 Jan;24(1):123-34
    Rothfuss A et al
    2004/01/01
  • 備考:
    Immunofluorescence, Western Blot, human
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Donahue SL et al. A Rad50-dependent pathway of DNA repair is deficient in Fanconi anemia fibroblasts. Nucleic Acids Res. 2004;32(10):3248-57
    Donahue SL et al
    2004/01/01
  • 備考:
    Human
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Stiff T et al. Nbs1 is required for ATR-dependent phosphorylation events. EMBO J. 2005 Jan;24(1):199-208
    Stiff T et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Bekker-Jensen S et al. Spatial organization of the mammalian genome surveillance machinery in response to DNA strand breaks. J. Cell Biol. 2006 Apr;173(2):195-206
    Bekker-Jensen S et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Tremblay S et al. Young patients with oral squamous cell carcinoma: study of the involvement of GSTP1 and deregulation of the Fanconi anemia genes. Arch. Otolaryngol. Head Neck Surg. 2006 Sep;132(9):958-66
    Tremblay S et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Mukhopadhyay SS et al. Defective mitochondrial peroxiredoxin-3 results in sensitivity to oxidative stress in Fanconi anemia. J. Cell Biol. 2006 Oct;175(2):225-35
    Mukhopadhyay SS et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Dunn J et al. Activation of the Fanconi anemia/BRCA pathway and recombination repair in the cellular response to solar ultraviolet light. Cancer Res. 2006 Dec;66(23):11140-7
    Dunn J et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Oda T et al. Hsp90 regulates the Fanconi anemia DNA damage response pathway. Blood 2007 Jun;109(11):5016-26
    Oda T et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Jacquemont C et al. Proteasome function is required for DNA damage response and fanconi anemia pathway activation. Cancer Res. 2007 Aug;67(15):7395-405
    Jacquemont C et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Ceccaldi R et al. Spontaneous abrogation of the G&#x2082;DNA damage checkpoint has clinical benefits but promotes leukemogenesis in Fanconi anemia patients. J. Clin. Invest. 2011 Jan;121(1):184-94
    Ceccaldi R et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Leung JW et al. Fanconi anemia (FA) binding protein FAAP20 stabilizes FA complementation group A (FANCA) and participates in interstrand cross-link repair. Proc. Natl. Acad. Sci. U.S.A. 2012 Mar;109(12):4491-6
    Leung JW et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Howlett NG et al. Functional interaction between the Fanconi Anemia D2 protein and proliferating cell nuclear antigen (PCNA) via a conserved putative PCNA interaction motif. J. Biol. Chem. 2009 Oct;284(42):28935-42
    Howlett NG et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Wright JW et al. Ovarian surface epitheliectomy in the non-human primate: continued cyclic ovarian function and limited epithelial replacement. Hum. Reprod. 2011 Jun;26(6):1422-30
    Wright JW et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Tremblay CS et al. HES1 is a novel interactor of the Fanconi anemia core complex. Blood 2008 Sep;112(5):2062-70
    Tremblay CS et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Dore-Duffy P et al. Immortalized CNS pericytes are quiescent smooth muscle actin-negative and pluripotent. Microvasc. Res. 2011 Jul;82(1):18-27
    Dore-Duffy P et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Bilardi RA et al. Processing of anthracycline-DNA adducts via DNA replication and interstrand crosslink repair pathways. Biochem. Pharmacol. 2012 May;83(9):1241-50
    Bilardi RA et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Lyakhovich A et al. Constitutive activation of caspase-3 and Poly ADP ribose polymerase cleavage in fanconi anemia cells. Mol. Cancer Res. 2010 Jan;8(1):46-56
    Lyakhovich A et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Stoepker C et al. SLX4, a coordinator of structure-specific endonucleases, is mutated in a new Fanconi anemia subtype. Nat. Genet. 2011 Feb;43(2):138-41
    Stoepker C et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Kavanaugh GM et al. The human DEK oncogene regulates DNA damage response signaling and repair. Nucleic Acids Res. 2011 Sep;39(17):7465-76
    Kavanaugh GM et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Jones MJ et al. Dysregulation of DNA polymerase &#x3BA; recruitment to replication forks results in genomic instability. EMBO J. 2012 Feb;31(4):908-18
    Jones MJ et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Baldeyron C et al. HP1alpha recruitment to DNA damage by p150CAF-1 promotes homologous recombination repair. J. Cell Biol. 2011 Apr;193(1):81-95
    Baldeyron C et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    Yang Y et al. Targeted disruption of the murine Fanconi anemia gene, Fancg/Xrcc9. Blood 2001 Dec;98(12):3435-40
    Yang Y et al
    2001/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 31
  • 文献情報:
    Kolas NK et al. Orchestration of the DNA-damage response by the RNF8 ubiquitin ligase. Science 2007 Dec;318(5856):1637-40
    Kolas NK et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 32
  • 文献情報:
    Bhagwat N et al. XPF-ERCC1 participates in the Fanconi anemia pathway of cross-link repair. Mol. Cell. Biol. 2009 Dec;29(24):6427-37
    Bhagwat N et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 33
  • 文献情報:
    Mason JM et al. Snm1B/Apollo functions in the Fanconi anemia pathway in response to DNA interstrand crosslinks. Hum. Mol. Genet. 2011 Jul;20(13):2549-59
    Mason JM et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 34
  • 文献情報:
    Brem R et al. Efficient DNA interstrand crosslinking by 6-thioguanine and UVA radiation. DNA Repair (Amst.) 2011 Aug;10(8):869-76
    Brem R et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 35
  • 文献情報:
    Jacome A et al. Lac operator repeats generate a traceable fragile site in mammalian cells. EMBO Rep. 2011 Oct;12(10):1032-8
    Jacome A et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 36
  • 文献情報:
    Kim Y et al. Mutations of the SLX4 gene in Fanconi anemia. Nat. Genet. 2011 Feb;43(2):142-6
    Kim Y et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 37
  • 文献情報:
    Hovest MG et al. Differential roles for Chk1 and FANCD2 in ATR-mediated signalling for psoralen photoactivation-induced senescence. Exp. Dermatol. 2011 Nov;20(11):883-9
    Hovest MG et al
    2011/01/01
  • 備考:
    Applications: WB, ICC, IF, Species: Human
  • 参照:
    PubMed
  • No.: 38
  • 文献情報:
    An JY et al. UBR2 of the N-end rule pathway is required for chromosome stability via histone ubiquitylation in spermatocytes and somatic cells. PLoS ONE 2012;7(5):e37414
    An JY et al
    2012/01/01
  • 備考:
    Applications: ICC, IF, Species: Mouse
  • 参照:
    PubMed
  • No.: 39
  • 文献情報:
    Ceccaldi R et al. Bone marrow failure in fanconi anemia is triggered by an exacerbated p53/p21 DNA damage response that impairs hematopoietic stem and progenitor cells. Cell Stem Cell 2012 Jul;11(1):36-49
    Ceccaldi R et al
    2012/01/01
  • 備考:
    Species: Human, Applications: WB, ICC/IF
  • 参照:
    PubMed
  • No.: 40
  • 文献情報:
    Panneerselvam J et al. FAVL impairment of the Fanconi anemia pathway promotes the development of human bladder cancer. Cell Cycle 2012 Aug;11(15):2947-55
    Panneerselvam J et al
    2012/01/01
  • 備考:
    Species: Human, Applications: WB, ICC/IF
  • 参照:
    PubMed
  • No.: 41
  • 文献情報:
    Wang Y et al. MiR-96 downregulates REV1 and RAD51 to promote cellular sensitivity to cisplatin and PARP inhibition. Cancer Res. 2012 Aug;72(16):4037-46
    Wang Y et al
    2012/01/01
  • 備考:
    Species: Human, Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 42
  • 文献情報:
    Hoskins EE et al. The fanconi anemia pathway limits human papillomavirus replication. J. Virol. 2012 Aug;86(15):8131-8
    Hoskins EE et al
    2012/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 43
  • 文献情報:
    Rego MA et al. Regulation of the Fanconi anemia pathway by a CUE ubiquitin-binding domain in the FANCD2 protein. Blood 2012 Sep;120(10):2109-17
    Rego MA et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 44
  • 文献情報:
    . ;

  • 備考:
    Applications: WB
  • 参照:
    PubMed
  • No.: 45
  • 文献情報:
    Duan W et al. Assessment of FANCD2 nuclear foci formation in paraffin-embedded tumors: a potential patient-enrichment strategy for treatment with DNA interstrand crosslinking agents. Transl Res 2012 Oct;
    Duan W et al
    2012/01/01
  • 備考:
    Species: Human, Applications: ICC/IF, IHC, IF
  • 参照:
    PubMed
  • No.: 46
  • 文献情報:
    Jacquemont C et al. Non-specific chemical inhibition of the Fanconi anemia pathway sensitizes cancer cells to cisplatin. Mol. Cancer 2012;11:26
    Jacquemont C et al
    2012/01/01
  • 備考:
    Species: Human, Applications: ICC/IF, WB
  • 参照:
    PubMed
  • No.: 47
  • 文献情報:
    Kim Y et al. Regulation of multiple DNA repair pathways by the Fanconi anemia protein SLX4. Blood 2012 Oct;
    Kim Y et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 48
  • 文献情報:
    Yüce Ö et al. Senataxin, defective in the neurodegenerative disorder ataxia with oculomotor apraxia 2, lies at the interface of transcription and the DNA damage response. Mol. Cell. Biol. 2013 Jan;33(2):406-17
    Yüce Ö et al
    2013/01/01
  • 備考:
    Species: Human, Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 49
  • 文献情報:
    Ogi T et al. Identification of the first ATRIP-deficient patient and novel mutations in ATR define a clinical spectrum for ATR-ATRIP Seckel Syndrome. PLoS Genet. 2012;8(11):e1002945
    Ogi T et al
    2012/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 50
  • 文献情報:
    Bhat A et al. Rev3, the catalytic subunit of Pol&#x3B6;, is required for maintaining fragile site stability in human cells. Nucleic Acids Res. 2013 Feb;41(4):2328-39
    Bhat A et al
    2013/01/01
  • 備考:
    Species: Human, Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 51
  • 文献情報:
    Gravells P et al. Reduced FANCD2 influences spontaneous SCE and RAD51 foci formation in uveal melanoma and Fanconi anaemia. Oncogene 2013 Jan;
    Gravells P et al
    2013/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 52
  • 文献情報:
    Wang Y et al. FANCM and FAAP24 Maintain Genome Stability via Cooperative as Well as Unique Functions. Mol. Cell 2013 Mar;49(5):997-1009
    Wang Y et al
    2013/01/01
  • 備考:
    Species: Human, Applications: WB, ICC/IF
  • 参照:
    PubMed
  • No.: 53
  • 文献情報:
    Duquette ML et al. CtIP is required to initiate replication-dependent interstrand crosslink repair. PLoS Genet. 2012;8(11):e1003050
    Duquette ML et al
    2012/01/01
  • 備考:
    Species: Human, Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 54
  • 文献情報:
    Fu D et al. Recruitment of DNA polymerase eta by FANCD2 in the early response to DNA damage. Cell Cycle 2013 Mar;12(5):803-9
    Fu D et al
    2013/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 55
  • 文献情報:
    Zhang P et al. Non-erythroid alpha spectrin prevents telomere dysfunction after DNA interstrand cross-link damage. Nucleic Acids Res. 2013 May;41(10):5321-40
    Zhang P et al
    2013/01/01
  • 備考:
    Species: Human, Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 56
  • 文献情報:
    Rego MA et al. Regulation of the activation of the Fanconi anemia pathway by the p21 cyclin-dependent kinase inhibitor. Oncogene 2012 Jan;31(3):366-75
    Rego MA et al
    2012/01/01
  • 備考:
    Species: Human, Applications: WB, ICC/IF
  • 参照:
    PubMed
  • No.: 57
  • 文献情報:
    Tomida J et al. A novel interplay between the Fanconi anemia core complex and ATR-ATRIP kinase during DNA cross-link repair. Nucleic Acids Res. 2013 May;
    Tomida J et al
    2013/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 58
  • 文献情報:
    Mason JM et al. The SNM1B/APOLLO DNA nuclease functions in resolution of replication stress and maintenance of common fragile site stability. Hum. Mol. Genet. 2013 Jul;
    Mason JM et al
    2013/01/01
  • 備考:
    Species: Human, Applications: WB, ICC/IF
  • 参照:
    PubMed
  • No.: 59
  • 文献情報:
    Ying S et al. MUS81 promotes common fragile site expression. Nat. Cell Biol. 2013 Aug;15(8):1001-7
    Ying S et al
    2013/01/01
  • 備考:
    Species: Human, Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 60
  • 文献情報:
    Colnaghi L et al. Patient-derived C-terminal mutation of FANCI causes protein mislocalization and reveals putative EDGE motif function in DNA repair. Blood 2011 Feb;117(7):2247-56
    Colnaghi L et al
    2011/01/01
  • 備考:
    Species: Human, Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 61
  • 文献情報:
    Pf辰ffle HN et al. EGFR-activating mutations correlate with a Fanconi anemia-like cellular phenotype that includes PARP inhibitor sensitivity. Cancer Res. 2013 Oct;73(20):6254-63
    Pf辰ffle HN et al
    2013/01/01
  • 備考:
    Species: Human, Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 62
  • 文献情報:
    Wang Y et al. Structure analysis of FAAP24 reveals single-stranded DNA-binding activity and domain functions in DNA damage response. Cell Res. 2013 Oct;23(10):1215-28
    Wang Y et al
    2013/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 63
  • 文献情報:
    Coulthard R et al. Architecture and DNA recognition elements of the Fanconi anemia FANCM-FAAP24 complex. Structure 2013 Sep;21(9):1648-58
    Coulthard R et al
    2013/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 64
  • 文献情報:
    Jun DW et al. Ouabain, a cardiac glycoside, inhibits the Fanconi anemia/BRCA pathway activated by DNA interstrand cross-linking agents. PLoS ONE 2013;8(10):e75905
    Jun DW et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 65
  • 文献情報:
    Boisvert RA et al. Coordinate nuclear targeting of the FANCD2 and FANCI proteins via a FANCD2 nuclear localization signal. PLoS ONE 2013;8(11):e81387
    Boisvert RA et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 66
  • 文献情報:
    Figueiredo N et al. Anthracyclines induce DNA damage response-mediated protection against severe sepsis. Immunity 2013 Nov;39(5):874-84
    Figueiredo N et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 67
  • 文献情報:
    Chlon TM et al. High-risk human papillomavirus E6 protein promotes reprogramming of Fanconi anemia patient cells through repression of p53 but does not allow for sustained growth of induced pluripotent stem cells. J. Virol. 2014 Oct;88(19):11315-26
    Chlon TM et al
    2014/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 68
  • 文献情報:
    Panneerselvam J et al. Basal level of FANCD2 monoubiquitination is required for the maintenance of a sufficient number of licensed-replication origins to fire at a normal rate. Oncotarget 2014 Mar;5(5):1326-37
    Panneerselvam J et al
    2014/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 69
  • 文献情報:
    Bursomanno S et al. Proteome-wide analysis of SUMO2 targets in response to pathological DNA replication stress in human cells. DNA Repair (Amst.) 2015 Jan;25:84-96
    Bursomanno S et al
    2015/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 70
  • 文献情報:
    Huard CC et al. The Fanconi anemia pathway has a dual function in Dickkopf-1 transcriptional repression. Proc. Natl. Acad. Sci. U.S.A. 2014 Feb;111(6):2152-7
    Huard CC et al
    2014/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 71
  • 文献情報:
    Stoepker C et al. DNA helicases FANCM and DDX11 are determinants of PARP inhibitor sensitivity. DNA Repair (Amst.) 2015 Feb;26:54-64
    Stoepker C et al
    2015/01/01
  • 備考:
    Species: Human, Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 72
  • 文献情報:
    Duan W et al. Fanconi anemia repair pathway dysfunction, a potential therapeutic target in lung cancer. Front Oncol 2014;4:368
    Duan W et al
    2014/01/01
  • 備考:
    Species: Human, Applications: WB, IHC-P
  • 参照:
    PubMed
  • No.: 73
  • 文献情報:
    Brem R et al. UVA photoactivation of DNA containing halogenated thiopyrimidines induces cytotoxic DNA lesions. J. Photochem. Photobiol. B, Biol. 2015 Apr;145:1-10
    Brem R et al
    2015/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 74
  • 文献情報:
    Aarts M et al. Functional Genetic Screen Identifies Increased Sensitivity to WEE1 Inhibition in Cells with Defects in Fanconi Anemia and HR Pathways. Mol. Cancer Ther. 2015 Apr;14(4):865-76
    Aarts M et al
    2015/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 75
  • 文献情報:
    Zhu B et al. K63-linked ubiquitination of FANCG is required for its association with the Rap80-BRCA1 complex to modulate homologous recombination repair of DNA interstand crosslinks. Oncogene 2014 Aug;
    Zhu B et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 76
  • 文献情報:
    Sarbajna S et al. Roles of SLX1-SLX4, MUS81-EME1, and GEN1 in avoiding genome instability and mitotic catastrophe. Genes Dev. 2014 May;28(10):1124-36
    Sarbajna S et al
    2014/01/01
  • 備考:
    Species: Human, Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 77
  • 文献情報:
    Xie J et al. RNF4-mediated polyubiquitination regulates the Fanconi anemia/BRCA pathway. J. Clin. Invest. 2015 Apr;125(4):1523-32
    Xie J et al
    2015/01/01
  • 備考:
    Species: Human, Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 78
  • 文献情報:
    Silva BA et al. DNA damage to a single chromosome end delays anaphase onset. J. Biol. Chem. 2014 Aug;289(33):22771-84
    Silva BA et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 79
  • 文献情報:
    Le VT et al. The cytomegaloviral protein pUL138 acts as potentiator of tumor necrosis factor (TNF) receptor 1 surface density to enhance ULb&quot;-encoded modulation of TNF-&#x3B1; signaling. J. Virol. 2011 Dec;85(24):13260-70
    Le VT et al
    2011/01/01
  • 備考:
    Applications: WB
  • 参照:
    PubMed
  • No.: 80
  • 文献情報:
    Demuth I et al. Human SNM1B is required for normal cellular response to both DNA interstrand crosslink-inducing agents and ionizing radiation. Oncogene 2004 Nov;23(53):8611-8
    Demuth I et al
    2004/01/01
  • 備考:
    Species: Human, Applications: IP
  • 参照:
    PubMed
  • No.: 81
  • 文献情報:
    Lu WT et al. The Fanconi anemia pathway is downregulated upon macrophage differentiation through two distinct mechanisms. Cell Cycle 2011 Oct;10(19):3300-10
    Lu WT et al
    2011/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 82
  • 文献情報:
    Smogorzewska A et al. A genetic screen identifies FAN1, a Fanconi anemia-associated nuclease necessary for DNA interstrand crosslink repair. Mol. Cell 2010 Jul;39(1):36-47
    Smogorzewska A et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 83
  • 文献情報:
    MacKay C et al. Identification of KIAA1018/FAN1, a DNA repair nuclease recruited to DNA damage by monoubiquitinated FANCD2. Cell 2010 Jul;142(1):65-76
    MacKay C et al
    2010/01/01
  • 備考:
    Species: Human, Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 84
  • 文献情報:
    Rickman KA et al. Deficiency of UBE2T, the E2&#xA0;Ubiquitin Ligase Necessary for FANCD2 and FANCI Ubiquitination, Causes FA-T Subtype of Fanconi Anemia. Cell Rep 2015 Jul;12(1):35-41
    Rickman KA et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 85
  • 文献情報:
    Chun MJ et al. Aurora A kinase is required for activation of the Fanconi anemia/BRCA pathway upon DNA damage. FEBS Open Bio 2016 Jul;6(7):782-90
    Chun MJ et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 86
  • 文献情報:
    Raya A et al. Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature 2009 Jul;460(7251):53-9
    Raya A et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 87
  • 文献情報:
    Stoepker C et al. Defects in the Fanconi Anemia Pathway and Chromatid Cohesion in Head and Neck Cancer. Cancer Res. 2015 Sep;75(17):3543-53
    Stoepker C et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 88
  • 文献情報:
    Zhou W et al. FAN1 mutations cause karyomegalic interstitial nephritis, linking chronic kidney failure to defective DNA damage repair. Nat. Genet. 2012 Aug;44(8):910-5
    Zhou W et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 89
  • 文献情報:
    Maeda J et al. Intrinsic Radiosensitivity and Cellular Characterization of 27 Canine Cancer Cell Lines. PLoS ONE 2016;11(6):e0156689
    Maeda J et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 90
  • 文献情報:
    Root H et al. FANCD2 limits BLM-dependent telomere instability in the alternative lengthening of telomeres pathway. Hum. Mol. Genet. 2016 Jul;
    Root H et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 91
  • 文献情報:
    Collis SJ et al. HCLK2 is essential for the mammalian S-phase checkpoint and impacts on Chk1 stability. Nat. Cell Biol. 2007 Apr;9(4):391-401
    Collis SJ et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 92
  • 文献情報:
    Oka Y et al. Ubiquitin-like protein UBL5 promotes the functional integrity of the Fanconi anemia pathway. EMBO J. 2015 May;34(10):1385-98
    Oka Y et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 93
  • 文献情報:
    Zhang T et al. Loss of Faap20 Causes Hematopoietic Stem and Progenitor Cell Depletion in Mice Under Genotoxic Stress. Stem Cells 2015 Jul;33(7):2320-30
    Zhang T et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 94
  • 文献情報:
    Panneerselvam J et al. BLM promotes the activation of Fanconi Anemia signaling pathway. Oncotarget 2016 May;7(22):32351-61
    Panneerselvam J et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 95
  • 文献情報:
    Minocherhomji S et al. Replication stress activates DNA repair synthesis in mitosis. Nature 2015 Dec;528(7581):286-90
    Minocherhomji S et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 96
  • 文献情報:
    Wang F et al. Leukemic survival factor SALL4 contributes to defective DNA damage repair. Oncogene 2016 May;
    Wang F et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 97
  • 文献情報:
    Bouffard F et al. Analysis of a FANCE Splice Isoform in Regard to DNA Repair. J. Mol. Biol. 2015 Sep;427(19):3056-73
    Bouffard F et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 98
  • 文献情報:
    Deans AJ et al. FANCM connects the genome instability disorders Bloom&quot;s Syndrome and Fanconi Anemia. Mol. Cell 2009 Dec;36(6):943-53
    Deans AJ et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 99
  • 文献情報:
    Ellwood SR et al. A first genome assembly of the barley fungal pathogen Pyrenophora teres f. teres. Genome Biol. 2010;11(11):R109
    Ellwood SR et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 100
  • 文献情報:
    Puri S et al. Control of bacterial iron homeostasis by manganese. Proc. Natl. Acad. Sci. U.S.A. 2010 Jun;107(23):10691-5
    Puri S et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 101
  • 文献情報:
    Willers H et al. Biomarkers and mechanisms of FANCD2 function. J. Biomed. Biotechnol. 2008;2008:821529
    Willers H et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 102
  • 文献情報:
    Puspasari N et al. Long range regulation of human FXN gene expression. PLoS ONE 2011;6(7):e22001
    Puspasari N et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 103
  • 文献情報:
    Fairclough SR et al. Multicellular development in a choanoflagellate. Curr. Biol. 2010 Oct;20(20):R875-6
    Fairclough SR et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 104
  • 文献情報:
    Rivera T et al. Recycling cohesin rings by deacetylation. Mol. Cell 2010 Sep;39(5):657-9
    Rivera T et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 105
  • 文献情報:
    Hays LE. Multifunctionality of the FA pathway. Blood 2013 Jan;121(1):3-4
    Hays LE
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 106
  • 文献情報:
    Asur RS et al. Somatic mosaicism of an intragenic FANCB duplication in both fibroblast and peripheral blood cells observed in a Fanconi anemia patient leads to milder phenotype. Mol Genet Genomic Med 2018 01;6(1):77-91
    Asur RS et al
    2018/01/01
  • 備考:
    Species: Human, Applications: WB, ICC/IF
  • 参照:
    PubMed
  • No.: 107
  • 文献情報:
    Bharathan SP et al. Generation of an induced pluripotent stem cell line that mimics the disease phenotypes from a patient with Fanconi anemia by conditional complementation. Stem Cell Res 2017 04;20:54-57
    Bharathan SP et al
    2017/01/01
  • 備考:
    Species: Human, Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 108
  • 文献情報:
    Bou Samra E et al. A role for Tau protein in maintaining ribosomal DNA stability and cytidine deaminase-deficient cell survival. Nat Commun 2017 Sep;8(1):693
    Bou Samra E et al
    2017/01/01
  • 備考:
    Species: Human, Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 109
  • 文献情報:
    Porro A et al. FAN1 interaction with ubiquitylated PCNA alleviates replication stress and preserves genomic integrity independently of BRCA2. Nat Commun 2017 10;8(1):1073
    Porro A et al
    2017/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 110
  • 文献情報:
    Alavattam KG et al. Elucidation of the Fanconi Anemia Protein Network in Meiosis and Its Function in the Regulation of Histone Modifications. Cell Rep 2016 10;17(4):1141-1157
    Alavattam KG et al
    2016/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 111
  • 文献情報:
    Balcerek J et al. Lnk/Sh2b3 deficiency restores hematopoietic stem cell function and genome integrity in Fancd2 deficient Fanconi anemia. Nat Commun 2018 09;9(1):3915
    Balcerek J et al
    2018/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 112
  • 文献情報:
    Chun MJ et al. Fanconi anemia protein FANCD2 is activated by AICAR, a modulator of AMPK and cellular energy metabolism. FEBS Open Bio 2017 Feb;7(2):284-292
    Chun MJ et al
    2017/01/01
  • 備考:
    Species: Human, Applications: WB, ICC/IF
  • 参照:
    PubMed
  • No.: 113
  • 文献情報:
    Andrews AM et al. A senataxin-associated exonuclease SAN1 is required for resistance to DNA interstrand cross-links. Nat Commun 2018 07;9(1):2592
    Andrews AM et al
    2018/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 114
  • 文献情報:
    Sato K et al. FANCI-FANCD2 stabilizes the RAD51-DNA complex by binding RAD51 and protects the 5&quot;-DNA end. Nucleic Acids Res. 2016 12;44(22):10758-10771
    Sato K et al
    2016/01/01
  • 備考:
    Species: Human, Applications: RNAi, WB
  • 参照:
    PubMed
  • No.: 115
  • 文献情報:
    Jiang J et al. Arsenite Binds to the RING Finger Domain of FANCL E3 Ubiquitin Ligase and Inhibits DNA Interstrand Crosslink Repair. ACS Chem. Biol. 2017 07;12(7):1858-1866
    Jiang J et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 116
  • 文献情報:
    Tremblay CS et al. Fanconi anemia core complex-dependent HES1 mono-ubiquitination regulates its transcriptional activity. BMC Res Notes 2018 Feb;11(1):138
    Tremblay CS et al
    2018/01/01
  • 備考:
    Species: Human, Applications:
  • 参照:
    PubMed
  • No.: 117
  • 文献情報:
    Bezine E et al. Cell resistance to the Cytolethal Distending Toxin involves an association of DNA repair mechanisms. Sci Rep 2016 Oct;6:36022
    Bezine E et al
    2016/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 118
  • 文献情報:
    Vuono EA et al. The PTEN phosphatase functions cooperatively with the Fanconi anemia proteins in DNA crosslink repair. Sci Rep 2016 11;6:36439
    Vuono EA et al
    2016/01/01
  • 備考:
    Species: Human, Applications:
  • 参照:
    PubMed
  • No.: 119
  • 文献情報:
    Moriel-Carretero M et al. Fanconi anemia FANCD2 and FANCI proteins regulate the nuclear dynamics of splicing factors. J. Cell Biol. 2017 12;216(12):4007-4026
    Moriel-Carretero M et al
    2017/01/01
  • 備考:
    Species: Human, Applications:
  • 参照:
    PubMed
  • No.: 120
  • 文献情報:
    Higgs MR et al. Histone Methylation by SETD1A Protects Nascent DNA through the Nucleosome Chaperone Activity of FANCD2. Mol. Cell 2018 Jul;71(1):25-41.e6
    Higgs MR et al
    2018/01/01
  • 備考:
    Species: Human, Applications:
  • 参照:
    PubMed
  • No.: 121
  • 文献情報:
    Vierra DA et al. Modulation of the Fanconi anemia pathway <i>via</i> chemically induced changes in chromatin structure. Oncotarget 2017 Sep;8(44):76443-76457
    Vierra DA et al
    2017/01/01
  • 備考:
    Species: Human, Applications: WB, ICC/IF
  • 参照:
    PubMed
  • No.: 122
  • 文献情報:
    Preiss MR et al. Tuning the Multifunctionality of Iron Oxide Nanoparticles Using Self-Assembled Mixed Lipid Layers. Bioconjug. Chem. 2017 11;28(11):2729-2736
    Preiss MR et al
    2017/01/01
  • 備考:
    WB
  • 参照:
    PubMed
  • No.: 123
  • 文献情報:
    Spriggs CC et al. FANCD2 Binds Human Papillomavirus Genomes and Associates with a Distinct Set of DNA Repair Proteins to Regulate Viral Replication. MBio 2017 02;8(1)
    Spriggs CC et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 124
  • 文献情報:
    Kais Z et al. FANCD2 Maintains Fork Stability in BRCA1/2-Deficient Tumors and Promotes Alternative End-Joining DNA Repair. Cell Rep 2016 06;15(11):2488-99
    Kais Z et al
    2016/01/01
  • 備考:
    WB
  • 参照:
    PubMed
  • No.: 125
  • 文献情報:
    Marchesini M et al. ILF2 Is a Regulator of RNA Splicing and DNA Damage Response in 1q21-Amplified Multiple Myeloma. Cancer Cell 2017 07;32(1):88-100.e6
    Marchesini M et al
    2017/01/01
  • 備考:
    Species: Human, Applications:
  • 参照:
    PubMed
  • No.: 126
  • 文献情報:
    Michl J et al. FANCD2 limits replication stress and genome instability in cells lacking BRCA2. Nat. Struct. Mol. Biol. 2016 08;23(8):755-757
    Michl J et al
    2016/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 127
  • 文献情報:
    Niraj J et al. The identification of FANCD2 DNA binding domains reveals nuclear localization sequences. Nucleic Acids Res. 2017 Aug;45(14):8341-8357
    Niraj J et al
    2017/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 128
  • 文献情報:
    Hooks KB et al. New insights into diagnosis and therapeutic options for proliferative hepatoblastoma. Hepatology 2018 07;68(1):89-102
    Hooks KB et al
    2018/01/01
  • 備考:
    Species: Human, Applications: WB, ICC/IF
  • 参照:
    PubMed
  • No.: 129
  • 文献情報:
    Feng W et al. BRCA2 suppresses replication stress-induced mitotic and G1 abnormalities through homologous recombination. Nat Commun 2017 09;8(1):525
    Feng W et al
    2017/01/01
  • 備考:
    Species: Human, Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 130
  • 文献情報:
    Kim J et al. Replication Stress Shapes a Protective Chromatin Environment across Fragile Genomic Regions. Mol. Cell 2018 01;69(1):36-47.e7
    Kim J et al
    2018/01/01
  • 備考:
    Species: Human, Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 131
  • 文献情報:
    Sakasai R et al. Aquarius is required for proper CtIP expression and homologous recombination repair. Sci Rep 2017 Oct;7(1):13808
    Sakasai R et al
    2017/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 132
  • 文献情報:
    Chang EY et al. RECQ-like helicases Sgs1 and BLM regulate R-loop-associated genome instability. J. Cell Biol. 2017 12;216(12):3991-4005
    Chang EY et al
    2017/01/01
  • 備考:
    Species: Human, Applications:
  • 参照:
    PubMed
  • No.: 133
  • 文献情報:
    Tacconi EM et al. BRCA1 and BRCA2 tumor suppressors protect against endogenous acetaldehyde toxicity. EMBO Mol Med 2017 10;9(10):1398-1414
    Tacconi EM et al
    2017/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 134
  • 文献情報:
    Lv Z et al. S.&#xA0;pombe Uba1-Ubc15 Structure Reveals a Novel Regulatory Mechanism of Ubiquitin E2 Activity. Mol. Cell 2017 Feb;65(4):699-714.e6
    Lv Z et al
    2017/01/01
  • 備考:
    WB
  • 参照:
    PubMed
  • No.: 135
  • 文献情報:
    Fu C et al. Dearth and Delayed Maturation of Testicular Germ Cells in Fanconi Anemia E Mutant Male Mice. PLoS ONE 2016;11(8):e0159800
    Fu C et al
    2016/01/01
  • 備考:
    IHC
  • 参照:
    PubMed
  • No.: 136
  • 文献情報:
    Zhu J et al. FANCD2 influences replication fork processes and genome stability in response to clustered DSBs. Cell Cycle 2015;14(12):1809-22
    Zhu J et al
    2015/01/01
  • 備考:
    WB
  • 参照:
    PubMed
  • No.: 137
  • 文献情報:
    Huang Y et al. Modularized functions of the Fanconi anemia core complex. Cell Rep 2014 Jun;7(6):1849-57
    Huang Y et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 138
  • 文献情報:
    Bi J et al. MTDH/AEG-1 downregulation using pristimerin-loaded nanoparticles inhibits Fanconi anemia proteins and increases sensitivity to platinum-based chemotherapy. Gynecol Oncol 2019 11;155(2):349-358
    Bi J et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 139
  • 文献情報:
    Sonneville R et al. TRAIP drives replisome disassembly and mitotic DNA repair synthesis at sites of incomplete DNA replication. Elife 2019 09;8
    Sonneville R et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 140
  • 文献情報:
    Miller HE et al. Reconstruction of Ewing Sarcoma Developmental Context from Mass-Scale Transcriptomics Reveals Characteristics of EWSR1-FLI1 Permissibility. Cancers (Basel) 2020 Apr;12(4)
    Miller HE et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 141
  • 文献情報:
    Johnson SF et al. CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer. Cell Rep 2016 11;17(9):2367-2381
    Johnson SF et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 142
  • 文献情報:
    Wilkes DC et al. A germline FANCA alteration that is associated with increased sensitivity to DNA damaging agents. Cold Spring Harb Mol Case Stud 2017 Sep;3(5)
    Wilkes DC et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 143
  • 文献情報:
    Shao X et al. A distinct role for recombination repair factors in an early cellular response to transcription-replication conflicts. Nucleic Acids Res 2020 06;48(10):5467-5484
    Shao X et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 144
  • 文献情報:
    Tacconi EM et al. Chlorambucil targets BRCA1/2-deficient tumours and counteracts PARP inhibitor resistance. EMBO Mol Med 2019 07;11(7):e9982
    Tacconi EM et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 145
  • 文献情報:
    Paquin KL et al. FANCD2 Binding to H4K20me2 via a Methyl-Binding Domain Is Essential for Efficient DNA Cross-Link Repair. Mol. Cell. Biol. 2019 08;39(15)
    Paquin KL et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 146
  • 文献情報:
    Kreutmair S et al. Loss of the Fanconi anemia-associated protein NIPA causes bone marrow failure. J Clin Invest 2020 06;130(6):2827-2844
    Kreutmair S et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 147
  • 文献情報:
    Brannvoll A et al. The ZGRF1 Helicase Promotes Recombinational Repair of Replication-Blocking DNA Damage in Human Cells. Cell Rep 2020 07;32(1):107849
    Brannvoll A et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 148
  • 文献情報:
    Ardeljan D et al. Cell fitness screens reveal a conflict between LINE-1 retrotransposition and DNA replication. Nat Struct Mol Biol 2020 02;27(2):168-178
    Ardeljan D et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 149
  • 文献情報:
    Gemble S et al. Topoisomerase II&#x3B1; prevents ultrafine anaphase bridges by two mechanisms. Open Biol 2020 05;10(5):190259
    Gemble S et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 150
  • 文献情報:
    Chang EY et al. MRE11-RAD50-NBS1 promotes Fanconi Anemia R-loop suppression at transcription-replication conflicts. Nat Commun 2019 09;10(1):4265
    Chang EY et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 151
  • 文献情報:
    Li N et al. Cooperation of the NEIL3 and Fanconi anemia/BRCA pathways in interstrand crosslink repair. Nucleic Acids Res 2020 04;48(6):3014-3028
    Li N et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 152
  • 文献情報:
    Achuthankutty D et al. Regulation of ETAA1-mediated ATR activation couples DNA replication fidelity and genome stability. J Cell Biol 2019 12;218(12):3943-3953
    Achuthankutty D et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 153
  • 文献情報:
    Cai MY et al. Cooperation of the ATM and Fanconi Anemia/BRCA Pathways in Double-Strand Break End Resection. Cell Rep 2020 02;30(7):2402-2415.e5
    Cai MY et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 154
  • 文献情報:
    Kono T et al. Activation of DNA damage repair factors in HPV positive oropharyngeal cancers. Virology 2020 08;547:27-34
    Kono T et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 155
  • 文献情報:
    Mason JM et al. Non-enzymatic roles of human RAD51 at stalled replication forks. Nat Commun 2019 09;10(1):4410
    Mason JM et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 156
  • 文献情報:
    Xing M et al. Replication Stress Induces ATR/CHK1-Dependent Nonrandom Segregation of Damaged Chromosomes. Mol Cell 2020 05;78(4):714-724.e5
    Xing M et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 157
  • 文献情報:
    Fragkos M et al. Dicer prevents genome instability in response to replication stress. Oncotarget 2019 Jul;10(43):4407-4423
    Fragkos M et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 158
  • 文献情報:
    Olivieri M et al. A Genetic Map of the Response to DNA Damage in Human Cells. Cell 2020 07;182(2):481-496.e21
    Olivieri M et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 159
  • 文献情報:
    Yang Y et al. FANCL gene mutations in premature ovarian insufficiency. Hum Mutat 2020 05;41(5):1033-1041
    Yang Y et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 160
  • 文献情報:
    Gemble S et al. Identification and Analysis of Different Types of UFBs. Methods Mol Biol 2021;2153:187-192
    Gemble S et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 161
  • 文献情報:
    Ruiz-Torres S et al. Inherited DNA Repair Defects Disrupt the Structure and Function of Human Skin. Cell Stem Cell 2021 03;28(3):424-435.e6
    Ruiz-Torres S et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 162
  • 文献情報:
    Lach FP et al. Esophageal cancer as initial presentation of Fanconi anemia in patients with a hypomorphic <i>FANCA</i> variant. Cold Spring Harb Mol Case Stud 2020 12;6(6)
    Lach FP et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 163
  • 文献情報:
    Calzetta NL et al. Mus81-Eme1-dependent aberrant processing of DNA replication intermediates in mitosis impairs genome integrity. Sci Adv 2020 12;6(50)
    Calzetta NL et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 164
  • 文献情報:
    Di Marco S et al. RECQ5 Helicase Cooperates with MUS81 Endonuclease in Processing Stalled Replication Forks at Common Fragile Sites during Mitosis. Mol Cell 2017 Jun;66(5):658-671.e8
    Di Marco S et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 165
  • 文献情報:
    Gonz叩lez-Acosta D et al. PrimPol-mediated repriming facilitates replication traverse of DNA interstrand crosslinks. EMBO J 2021 Jul;40(14):e106355
    Gonz叩lez-Acosta D et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 166
  • 文献情報:
    Fang X et al. The HMGB1-AGER-STING1 pathway mediates the sterile inflammatory response to alkaliptosis. Biochem Biophys Res Commun 2021 06;560:165-171
    Fang X et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 167
  • 文献情報:
    Ishimoto R et al. SLX4-XPF mediates DNA damage responses to replication stress induced by DNA-protein interactions. J Cell Biol 2021 01;220(1)
    Ishimoto R et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 168
  • 文献情報:
    Jones MJK et al. Human DDK rescues stalled forks and counteracts checkpoint inhibition at unfired origins to complete DNA replication. Mol Cell 2021 02;81(3):426-441.e8
    Jones MJK et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 169
  • 文献情報:
    Watts LP et al. The RIF1-long splice variant promotes G1 phase 53BP1 nuclear bodies to protect against replication stress. Elife 2020 11;9
    Watts LP et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 170
  • 文献情報:
    Duan W et al. MiRNA-200C expression in Fanconi anemia pathway functionally deficient lung cancers. Sci Rep 2021 Feb;11(1):4420
    Duan W et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 171
  • 文献情報:
    Zhang T et al. Fancd2 in vivo interaction network reveals a non-canonical role in mitochondrial function. Sci Rep 2017 04;7:45626
    Zhang T et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 172
  • 文献情報:
    Young SJ et al. MutS&#x3B2; Stimulates Holliday Junction Resolution by the SMX Complex. Cell Rep 2020 10;33(3):108289
    Young SJ et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 173
  • 文献情報:
    Ma C et al. TFG-maintaining stability of overlooked FANCD2 confers early DNA-damage response. Aging (Albany NY) 2020 10;12(20):20268-20284
    Ma C et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 174
  • 文献情報:
    Ren L et al. Potential biomarkers of DNA replication stress in cancer. Oncotarget 2017 Jun;8(23):36996-37008
    Ren L et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed